About this trial
The aim of the study is to reduce postoperative pain by performing rectointercostal block in L/S cholecystectomy surgeries. Main goal is to provide well managed post-operative analgesia.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
BMI < 35 kg/m²
Patients with ASA scores I and II
Disqualifiers
Patients who do not want to be included in the study
Psychiatric and neurological disease with blurred consciousness
Patients with ASA > 3
BMI > 35 kg/m²
Trial design
Single group
Treatments tested in this trial
Rectointercostal facial plane block using bupivacaine 0.25%
Procedure/SurgeryUnder ultrasound guidance, a total of 30 mL of solution will be administered bilaterally between the rectus abdominis muscle and the intercostal muscles, at the level of the 6th and 7th costal cartilages bilaterally.
Treatment groups
Trial outcomes
Primary outcomes
Postoperative opioid consumption
Contramal consumption in the first 24 hours after surgery
Secondary outcomes
NRS Scores
NRS scores in the first 24 hours after surgery
Quality of recovery
QR15 scores
Nausea and vomiting
Nausea and vomiting scores in the first 24 hours
Sponsors and contacts
Click on the lead sponsor to view all of their trials.